Search

Author/Creator Collis, Alan

1. 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. (9th November 2020)

Authors:
Ciccone, David; Lazari, Vad; Linney, Ian; Briggs, Michael; Carreiro, Samantha; McElwee, Joshua; Waddell, Ian; Hill, Chris; Loh, Christine; Tummino, Peter; Collis, Alan; Kaila, Neelu
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. (9th November 2020)

Authors:
Ciccone, David; Lazari, Vad; Linney, Ian; Briggs, Michael; Carreiro, Samantha; McElwee, Joshua; Waddell, Ian; Hill, Chris; Loh, Christine; Tummino, Peter; Collis, Alan; Kaila, Neelu
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11. Issue 12 (1st July 2018)

Authors:
Martin, Matthew W.; Lee, Jennifer Y.; Lancia, David R.; Ng, Pui Yee; Han, Bingsong; Thomason, Jennifer R.; Lynes, Maureen S.; Marshall, C. Gary; Conti, Chiara; Collis, Alan; Morales, Monica Alvarez; Doshi, Kshama; Rudnitskaya, Aleksandra; Yao, Lili; Zheng, Xiaozhang
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 28:Issue 12(2018)
Page Start:
2143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗